Skip to content
Sermorelin Picks
← Research
Safety

What Not to Mix With Sermorelin: Drug Interactions Explained

Short answer

No interaction study has been published for sermorelin itself. What the evidence does show: a steroid course cut the growth hormone response by about 85% in one study, an untreated underactive thyroid weakens it, and growth hormone can raise blood sugar. That matters if you take insulin or a GLP-1. Tell your prescriber about every medication.

Steroids, thyroid status, somatostatin drugs and anything for blood sugar are the medicines worth raising before starting sermorelin. Here is what each source actually shows, including the GLP-1 and testosterone questions.

Adrian Osei7 min read
What can change how sermorelin worksNo interaction study exists for sermorelin itselfMedication or conditionEffectSourceGlucocorticoids (prednisone, cortisone)Can blunt the GH responsehuman studiesUnderactive thyroid, untreatedWeaker GH responsehuman studySomatostatin analogs (octreotide)Inhibit GH directlySandostatin labelInsulin, diabetes drugs, GLP-1sWatch blood sugartesamorelin labelLabels for tesamorelin and octreotide are those drugs' labels, not sermorelin's.

The short version: there is no published list of drugs that interact with sermorelin, because the only sermorelin product that ever had an FDA label, Geref, was discontinued and its labeling is not in the FDA’s searchable label database [1]. What does exist is a set of small human studies that gave sermorelin’s exact peptide alongside other drugs, plus the current label of tesamorelin, its closest approved relative [2]. Together they point to a short list of medicines worth raising with whoever prescribes it.

What should you not mix with sermorelin?

Nothing is formally contraindicated alongside sermorelin, because no current sermorelin label exists to say so. The question a prescriber actually works through is narrower: which drugs change the growth hormone response sermorelin is meant to produce, and which drugs become harder to manage once growth hormone rises. Four groups come up, each for a different reason.

  • Glucocorticoids such as prednisone, dexamethasone and cortisone, which can blunt the response and whose own dosing may need a second look.
  • Thyroid status: an untreated underactive thyroid weakens the response, and treating it restores much of it.
  • Somatostatin analogs such as octreotide, which suppress growth hormone directly and pull in the opposite direction.
  • Anything that manages blood sugar, including insulin, metformin and the GLP-1 drugs, because growth hormone works against insulin.

A search of PubMed for sermorelin together with interaction or glucocorticoid terms returns 26 records. None is a drug-interaction study of sermorelin taken as a treatment; most are animal or cell-level papers about the GHRH receptor [10]. The studies cited below come from the separate human literature on GHRH(1-29), which is the same 29-amino-acid sequence. Who should avoid the drug altogether is a different question, covered in who should not take sermorelin.

Do steroids like prednisone interfere with sermorelin?

They can, and this is the best-documented interaction on the list. In six healthy adults given an intravenous dose of GHRH(1-29), taking 25 mg of oral cortisone acetate an hour beforehand significantly lowered the growth hormone peak, and 50 mg lowered it further. The authors described the effect as dose-dependent [3]. In eight healthy men, two days of dexamethasone (2 mg every six hours) cut the growth hormone response to GHRH from an area under the curve of 4,267 to 634 mU/min per liter, roughly an 85% reduction [4].

The dose matters. In six patients with adrenal insufficiency, a hydrocortisone infusion sized to produce ordinary cortisol levels did not change the response to GHRH, while higher infusions cut the peak to about 70% of baseline. The authors put the threshold at a serum cortisol of roughly 700 nmol/L [11]. In plain terms, a replacement dose that brings cortisol back to normal is not the same exposure as a course of prednisone for a flare.

The interaction also runs the other way. Tesamorelin’s label states that growth hormone inhibits 11β-HSD-1, the enzyme that converts cortisone to active cortisol. It says people on glucocorticoid replacement for adrenal insufficiency “may require an increase in maintenance or stress doses” after starting the drug, and that cortisone acetate and prednisone may be affected most [2]. That is tesamorelin’s label. Sermorelin raises growth hormone the same way, so a prescriber has the same reason to ask.

Does thyroid medication affect sermorelin?

Thyroid hormone itself is not the problem; an untreated thyroid deficiency is. Fourteen adults with primary hypothyroidism, aged 26 to 60, were tested with GHRH(1-29) before and during thyroxine replacement. On treatment, the average growth hormone peak nearly doubled, from 17.0 to 32.6 mU/L, and the area under the curve rose from 51.7 to 101.5 [5]. Someone with an undertreated thyroid may get a weaker response than the dose would otherwise produce, which is one reason a thyroid panel shows up in some sermorelin lab work. What sermorelin bloodwork usually covers explains where thyroid fits and where the published guidance thins out.

What about octreotide and other somatostatin drugs?

Somatostatin is the body’s brake on growth hormone, and sermorelin is a pedal. Octreotide, sold as Sandostatin, is described in its own label as “an even more potent inhibitor of GH, glucagon, and insulin than somatostatin” [6]. Nobody has published a study of the two given together, and few people prescribed a somatostatin analog for acromegaly or a hormone-secreting tumor would be candidates for a growth hormone booster anyway. The point is directional: one drug exists to lower growth hormone and the other to raise it.

One more finding from the same research era is worth knowing if you take an anticholinergic. In healthy volunteers, a dose of atropine given before GHRH(1-29) significantly reduced the growth hormone response. Blocking dopamine or alpha-adrenergic receptors did not [7]. That was a single intravenous dose in a test setting, not a daily tablet, so it is a reason to mention the medicine rather than a known clinical problem.

Can you take sermorelin with tirzepatide or semaglutide?

No study has tested them together. A PubMed search pairing sermorelin with semaglutide, tirzepatide, liraglutide, exenatide or glucagon-like peptide returns zero records [10]. Semaglutide and tirzepatide are peptides too, but they act on different receptors and do a different job, a distinction laid out in sermorelin for weight loss.

The one place the two meet on paper is blood sugar. Tesamorelin’s label reports that 5% of people on the drug reached an HbA1c of 6.5% or higher by week 26, against 1% on placebo. It tells prescribers to check glucose before and during treatment [2]. Sermorelin’s own trial in older adults saw no change in fasting glucose or insulin, and insulin sensitivity actually improved in the men [8]. That is reassuring but small: nineteen people, five months. Anyone taking a GLP-1, insulin or another diabetes drug has a reason to keep the same glucose checks going after adding sermorelin, and to tell both prescribers about both drugs.

Can you take sermorelin with testosterone?

There is no interaction study, and the only human data on the pairing comes from a chart review. Fourteen men already on testosterone therapy, average age 33, took a combination of sermorelin with two other growth hormone secretagogues. Their mean IGF-1 rose from 159.5 to 239.0 ng/mL [9]. The detail that matters for interactions sits in the same paper: men who were also taking an aromatase inhibitor or tamoxifen had smaller IGF-1 increases. That suggests estrogen-blocking drugs, often added to testosterone therapy, may dampen the effect.

Tesamorelin’s label adds a general caution: growth hormone may change how fast the liver clears drugs processed by CYP450 enzymes, and it names sex steroids, corticosteroids, anticonvulsants and cyclosporine as examples [2]. How the two hormones compare as treatments is a separate question, answered in sermorelin vs. testosterone.

Does alcohol interact with sermorelin?

No published study has looked. Of the 11 PubMed records that mention sermorelin alongside alcohol or ethanol, none involves people drinking; they are lab chemistry and animal studies [10]. Because sermorelin is usually injected at bedtime to line up with the night’s natural growth hormone release, timing questions like this one are covered with the half-life and other small questions.

Which health conditions change the answer?

Three conditions turn a general caution into a specific one. Adrenal insufficiency on hydrocortisone or prednisone replacement, because of the dosing note on the related label. Diabetes or prediabetes, because of the glucose finding. And a thyroid disorder that is not yet well controlled, because it changes how strongly the pituitary responds. Pituitary disease, active cancer and pregnancy sit in a different category: those are reasons the related drug is not used at all, not interactions to manage.

What to tell a telehealth prescriber

Most sermorelin is prescribed online, through an intake form rather than a visit, so the medication list you type is often the only one the prescriber sees. Name every prescription, including steroid tapers and inhalers you use often, thyroid medication and its dose, anything for blood sugar or weight, testosterone and any estrogen blocker taken with it, and supplements sold for growth hormone or sleep. Ask whether a baseline IGF-1 and fasting glucose will be drawn. The questions worth asking a sermorelin prescriber go further, and how to get a sermorelin prescription walks through the steps that come before it.

Frequently asked

What should you not mix with sermorelin?
No drug is formally contraindicated with sermorelin, because no current sermorelin label exists. The medicines worth raising with a prescriber are glucocorticoids such as prednisone, which can blunt the growth hormone response; thyroid medication, if the thyroid is not yet well controlled; somatostatin analogs such as octreotide; and anything that manages blood sugar.
Can you take sermorelin and tirzepatide or semaglutide together?
No study has tested sermorelin with any GLP-1 drug; a PubMed search pairing them returns zero records. The overlap to watch is blood sugar: the label for tesamorelin, a related drug, reports higher HbA1c in 5% of users versus 1% on placebo, so glucose checks are worth keeping up on both drugs.
Can you take sermorelin with testosterone?
There is no interaction study. The only human data is a chart review of 14 men on testosterone therapy who took sermorelin with two other secretagogues; their IGF-1 rose from about 160 to 239 ng/mL. Men also taking an aromatase inhibitor or tamoxifen had smaller increases.
Does prednisone stop sermorelin from working?
It can weaken it. In healthy men, two days of dexamethasone cut the growth hormone response to GHRH by roughly 85%, and a single dose of cortisone acetate lowered it in a dose-dependent way. Replacement-level hydrocortisone that only restores normal cortisol did not blunt the response in a study of adrenal-insufficiency patients.
Can you drink alcohol on sermorelin?
No published study has tested alcohol with sermorelin. None of the 11 PubMed records mentioning both involves people drinking. Ask the prescriber, especially if you inject at bedtime.

Sources

  1. [1] U.S. Food and Drug Administration, Drugs@FDA (openFDA drugsfda and drug label endpoints) (2026). GEREF (sermorelin acetate), NDA019863 and NDA020443, EMD Serono — both marketing status "Discontinued"; drugsfda lists every submission, and the label endpoint returns no Geref labeling. Queried October 2, 2026. openFDA. Source
  2. [2] U.S. Food and Drug Administration (openFDA drug label) (2026). EGRIFTA SV (tesamorelin), BLA022505, Theratechnologies — prescribing information effective July 29, 2026: §5.4 Glucose Intolerance or Diabetes Mellitus; §7.1 Cytochrome P450-Metabolized Drugs; §7.2 Glucocorticoids openFDA. Source
  3. [3] Giustina A, Doga M, Bodini C, et al. (1990). Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects Acta Endocrinologica (Copenhagen). PMID 2107653
  4. [4] Trainer PJ, Kirk JM, Savage MO, Grossman AB, Besser GM. (1992). Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone Journal of Endocrinology. PMID 1357070
  5. [5] Valcavi R, Jordan V, Dieguez C, et al. (1986). Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxine Clinical Endocrinology (Oxford). PMID 3098458
  6. [6] U.S. Food and Drug Administration (openFDA drug label) (2026). Sandostatin (octreotide acetate) injection, NDA019667 — prescribing information effective July 22, 2026: §12.1 Mechanism of Action openFDA. Source
  7. [7] Jordan V, Dieguez C, Lafaffian I, et al. (1986). Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29 Clinical Endocrinology (Oxford). PMID 2871952
  8. [8] Khorram O, Laughlin GA, Yen SS. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women Journal of Clinical Endocrinology and Metabolism. PMID 9141536
  9. [9] Sigalos JT, Pastuszak AW, Allison A, et al. (2017). Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels American Journal of Men's Health. PMID 28830317
  10. [10] PubMed search, October 2, 2026 (2026). sermorelin AND (interaction* OR glucocorticoid*) — 26 records, none a drug-interaction study of sermorelin as a treatment. sermorelin AND (semaglutide OR tirzepatide OR liraglutide OR exenatide OR "glucagon-like peptide") — 0 records. sermorelin AND (alcohol OR ethanol) — 11 records, none in people drinking alcohol. PubMed / NCBI E-utilities. Source
  11. [11] Giustina A, Bresciani E, Bossoni S, et al. (1994). Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency Journal of Clinical Endocrinology and Metabolism. PMID 7962318

More in Safety